World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
33393
World Ranking
11251
National Ranking
5775

Overview

Alan Pollack is affiliated with the University of Miami in the United States. The primary focus of their research lies within the field of Medicine, encompassing a broad range of topics related to cancer treatment, diagnosis, and medical imaging. Their work spans several subfields including Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Radiation, Cancer Research, and Surgery.

Pollack's research predominantly centers on prostate cancer, with significant contributions to prostate cancer treatment and research as well as diagnosis and treatment. Their interests also extend to radiomics and machine learning applications in medical imaging, advanced radiotherapy techniques, and cancer-related metabolism and genomics. They have additionally explored treatments relating to bladder and urothelial cancers.

The scientist has published extensively, contributing to various respected journals and forums. Frequent publication venues include:

  • International Journal of Radiation Oncology*Biology*Physics
  • Journal of Clinical Oncology
  • The Journal of Urology
  • Cancer Research
  • Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition

Some notable recent papers authored or coauthored by Alan Pollack include:

  • The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial, 2022, The Lancet
  • A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer, 2020, European Urology
  • Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer, 2021, JAMA Oncology
  • The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited, 2021, European Urology
  • Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy - an ancillary study of the SAKK 09/10 randomized clinical trial, 2022, Annals of Oncology

Alan Pollack collaborates frequently with a number of coauthors, reflecting an extensive network in their research community. Common collaborators include:

  • Radka Stoyanova
  • Alan Dal Pra
  • Matthew C. Abramowitz
  • Sanoj Punnen
  • Oleksandr N. Kryvenko

Best Publications

  • PROSTATE CANCER RADIATION DOSE RESPONSE: RESULTS OF THE M. D. ANDERSON PHASE III RANDOMIZED TRIAL

    Alan Pollack;Gunar K Zagars;George Starkschall;John A Antolak

  • Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

    Deborah A. Kuban;Susan L. Tucker;Lei Dong;George Starkschall

  • Prostate cancer. Clinical practice guidelines in oncology.

    James Mohler;Robert R. Bahnson;Barry Boston;J. Erik Busby

  • Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy

    Andrew J. Stephenson;Peter T. Scardino;Michael W. Kattan;Thomas M. Pisansky

  • Preliminary Results of a Randomized Radiotherapy Dose-Escalation Study Comparing 70 Gy With 78 Gy for Prostate Cancer

    Alan Pollack;Gunar K. Zagars;Lewis G. Smith;Jiun-Kae Jack Lee

  • Desmoid Tumor: Prognostic Factors and Outcome After Surgery, Radiation Therapy, or Combined Surgery and Radiation Therapy

    Matthew T. Ballo;Gunar K. Zagars;Alan Pollack;Peter W.T. Pisters

  • Primary treatment of cystosarcoma phyllodes of the breast.

    Arthur W. Chaney;Alan Pollack M.D.;Marsha D. Mcneese;Gunar K. Zagars

  • Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.

    Alan Pollack;Gail Walker;Eric M. Horwitz;Robert Price

  • Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial

    Mark R. Storey;Alan Pollack;Gunar K Zagars;Lewis Smith

  • Prognostic Factors in Prostate Cancer

    David G. Bostwick;David J. Grignon;M. Elizabeth H. Hammond;Mahul B. Amin

  • Bladder cancer. Clinical practice guidelines in oncology.

    Peter E. Clark;Neeraj Agarwal;Matthew C. Biagioli;Mario A. Eisenberger

  • Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy

    Rahul D. Tendulkar;Shree Agrawal;Tianming Gao;Jason A. Efstathiou

  • Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer.

    Eugene H Huang;Alan Pollack;Larry Levy;George Starkschall

  • Establishment of two human prostate cancer cell lines derived from a single bone metastasis.

    N M Navone;M Olive;M Ozen;R Davis

  • Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?

    Deborah A Kuban;Lawrence B. Levy;M. Rex Cheung;Andrew K. Lee

  • Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial

    Alan Pollack;Alexandra L. Hanlon;Eric M. Horwitz;Steven J. Feigenberg

  • Prostate target volume variations during a course of radiotherapy

    John A. Antolak;Isaac I. Rosen;Constance H. Childress;Gunar K. Zagars

  • External beam radiotherapy dose response of prostate cancer

    Alan Pollack;Gunar K. Zagars

  • Intrafraction prostate motion during IMRT for prostate cancer.

    Eugene Huang;Lei Dong;Anurag Chandra;Deborah A Kuban

  • Prostate cancer early detection. Clinical practice guidelines in oncology

    Mark H. Kawachi;Robert R. Bahnson;Michael Barry;J. Erik Busby

Frequent Co-Authors

Eric M. Horwitz
Eric M. Horwitz Fox Chase Cancer Center
Gunar K. Zagars
Gunar K. Zagars The University of Texas MD Anderson Cancer Center
Alexandra L. Hanlon
Alexandra L. Hanlon Virginia Tech
Robert G. Uzzo
Robert G. Uzzo Fox Chase Cancer Center
Gerald E. Hanks
Gerald E. Hanks Fox Chase Cancer Center
Howard M. Sandler
Howard M. Sandler Cedars-Sinai Medical Center
Deborah A. Kuban
Deborah A. Kuban The University of Texas MD Anderson Cancer Center
Andrew C. von Eschenbach
Andrew C. von Eschenbach United States Food and Drug Administration
William U. Shipley
William U. Shipley Harvard University
Marvin L. Meistrich
Marvin L. Meistrich The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn't always mean following the traditional MD path. Today, there are flexible alternatives that help students and career-changers enter the healthcare field. For those who want to advance quickly, direct msn programs online are designed for non-nurses looking to earn a master’s in nursing efficiently and with flexibility.

If you're interested in starting with a bachelor’s in nursing, you might consider applying to the easiest bsn program to get into, which could streamline your acceptance into a nursing career.

Alternative careers, such as medical billing and coding, are also in high demand. Many reputable medical billing and coding schools that accept fafsa offer online programs with financial aid options, making them accessible for many students.

For those concerned about standardized test barriers, there are also nursing schools that don't require teas or hesi, simplifying the entry process for aspiring nurses.

Whether pursuing clinical roles or administrative careers, these online pathways provide flexible opportunities to join the healthcare industry.

Best Scientists Citing Alan Pollack

Trending Scientists

Recently Published Articles